Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Abstract
It is generally thought that many drug molecules are transported across biological membranes via passive diffusion at a rate related to their lipophilicity. However, the types of biophysical forces involved in the interaction of drugs with lipid membranes are no different from those involved in their interaction with proteins, and so arguments based on lipophilicity could also be applied to drug uptake by membrane transporters or carriers. In this article, we discuss the evidence supporting the idea that rather than being an exception, carrier-mediated and active uptake of drugs may be more common than is usually assumed - including a summary of specific cases in which drugs are known to be taken up into cells via defined carriers - and consider the implications for drug discovery and development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Note that despite a widespread assumption that lipophilicity or log P is sufficient to account for drug distribution this is not in fact the case, as there are hundreds of natural transporters that drugs can use (e.g. [18,1714]).”
In the citing paper
“(Note that liophilicity per se may not be relevant, as drugs require carriers to cross membranes [18], and promiscuity and off-target effects increase with lipophilicity [1679].)”
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
CHEMIOSMOTIC COUPLING IN OXIDATIVE AND PHOTOSYNTHETIC PHOSPHORYLATION
MITCHELL, P. (1966) · Biological Reviews · doi:10.1111/j.1469-185x.1966.tb01501.x · Cited by 3,663
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Hucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg015 · Cited by 3,060
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512 · cited 1×
“, do not obey the Ro5 (for example, most antibacterial”
BackgroundThe influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403 · cited 1×
“This is because many of the recent trends in molecular drug design and development have been towards increased lipophilicity, leading to a greater likelihood of both a lack of selectivity and of attritio”
BackgroundThe Membrane Actions of Anesthetics and Tranquilizers
Seeman, P. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06931-5 · Cited by 2,246
Abraham, M. H. (1993) · Chemical Society Reviews · doi:10.1039/cs9932200073 · Cited by 1,968
Osmotic Stress Signaling and Osmoadaptation in Yeasts
Hohmann, S. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.2.300-372.2002 · Cited by 1,767
Research works printed but not linked: 1
- Jain, M. K. The Bimolecular Lipid Membrane. (Van Nostrand Reinhold, New York, 1972).
Cited by
Items 301–400 of 479
Tomas‐Hernández, S., Blanco, J., García-Vallvé, S., Pujadas, G., Ojeda, M. J., Gimeno, A., Arola, L., Minghetti, L., Beltrán‐Debón, R., & Mulero, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060806 · Cited by 15
“Nevertheless, it is assumed that the most important permeability process through the BBB is passive diffusion of small compounds, although active transport of compounds may be more significant than originally thought [18].”
BackgroundSulaiman, S. A. J., Al-Rasbi, G. S., & Abou‐Zied, O. K. (2016) · Luminescence · doi:10.1002/bio.3106 · Cited by 15
Kim, J. H., Chakraborty, S., Jayaprakasha, G. K., Muthuchamy, M., & Patil, B. S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.043 · Cited by 17
Maddi, S. (2017) · Open Journal of Chemistry · doi:10.17352/ojc.000006 · Cited by 19
“In the transport of a wide range of substrates, SLC and ABC transporters are involved and they share a wide distribution in the body [48].”
BackgroundKell, D., & Pretorius, E. (2016) · bioRxiv · doi:10.1101/054734 · Cited by 21
Self-citationZhou, T., Liu, Y., Lei, K., Liu, J., Hu, M., Guo, L., Guo, Y., & Ye, Q. (2023) · Molecules · doi:10.3390/molecules28041577 · Cited by 14
“Furthermore, research studies have shown that many drugs’ transmembrane transport is mediated by specific membrane transport proteins, rather than simple diffusion [21].”
BackgroundEffect of Chirality on Common in Vitro Experiments: An Enantiomeric Pair Analysis
Bagdanoff, J. T., Xu, Y., Dollinger, G. D., & Martin, É. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00552 · Cited by 14
Park, J. H., Ferhan, A. R., Jackman, J. A., & Cho, N. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.04.017 · Cited by 15
Hens, B., Corsetti, M., Bermejo, M., Löbenberg, R., González, P. M., Mitra, A., Desai, D. S., Chilukuri, D., & Aceituno, A. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0346-6 · Cited by 14
Control of metabolite efflux in microbial cell factories: current advances and future prospectsPreprint
Kell, D. B. (2018) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/xg9jh · Cited by 16
Self-citationHill, D. A., & Desai, S. A. (2009) · Future Microbiology · doi:10.2217/fmb.09.109 · Cited by 13
Edemir, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124491 · Cited by 15
“intracellular accumulation of xenobiotic drugs [7].”
Cheng, X., Shi, S., Wu, Y. P., Zhu, L., Xu, J., Hu, T., Wei, B., & Tang, R. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c01662 · Cited by 13
Development and Challenges of Nanovectors in Gene Therapy
Liu, Y., Rohrs, J. A., & Wang, P. (2014) · Nano LIFE · doi:10.1142/s1793984414410074 · Cited by 13
Intelligent host engineering for metabolic flux optimisation in biotechnology
Munro, L. J., & Kell, D. B. (2021) · Biochemical Journal · doi:10.1042/bcj20210535 · Cited by 12
Self-citationMunro, L. J., & Kell, D. B. (2022) · Antibiotics · doi:10.3390/antibiotics11081129 · Cited by 12
Self-citationpH-Dependent transport of amino acids across lipid bilayers by simple monotopic anion carriers
Maslowska-Jarzyna, K., Bąk, K. M., Zawada, B., & Chmielewski, M. J. (2022) · Chemical Science · doi:10.1039/d2sc04346g · Cited by 15
Caudana, F., Ermondi, G., Vallaro, M., Shalaeva, M. Y., & Caron, G. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0071 · Cited by 12
Drug Transporters: Recent Advances and Therapeutic Applications
Franke, R. M., & Sparreboom, A. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.239 · Cited by 12
Transporters in Anti‐Parasitic Drug Development and Resistance
Delespaux, V., & de Koning, H. P. (2013) · doi:10.1002/9783527670383.ch18 · Cited by 12
Truong, J. K., Li, J., Li, Q., Pachura, K. J., Rao, A., Gumber, S., Fuchs, C. D., Feranchak, A. P., Karpen, S. J., Trauner, M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.149360 · Cited by 12
“In contrast to biliary cholesterol, administration of norUDCA dramatically reduced biliary phospholipid secretion in both WT and Asbt-/- mice, in agreement with previous studies (13) and has been attributed to reduced surface activity and ability of norUDCA to extract phospholipid from the canalicular membrane (10).”
BackgroundResultUnderstanding therapeutic tolerance through a mathematical model of drug-induced resistance
Gevertz, J. L., Greene, J. M., Prosperi, S., Comandante-Lou, N., & Sontag, E. D. (2025) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00511-3 · Cited by 14
“Biologically, this delay in drug effect may be due to various factors such as drug uptake and engagement of the target 63 , initiation of the apoptotic pathway 64 , or cell-cycle inhibition 65 .”
De, V., Sutera, F. M., Gentile, C., Tutone, M., Livrea, M. A., Almerico, A. M., Cannizzaro, C., & Giannola, L. I. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1035275 · Cited by 11
“The p-glycoprotein efflux carrier expressed by both the Caco-2 monolayers [40] could be useful in providing information on the resistance to transport mechanism across BBB.”
BackgroundExpression and regulation of drug transporters in vertebrate neutrophils
Foulkes, M. J., Henry, K. M., Rougeot, J., Hooper‐Greenhill, E., Loynes, C. A., Jeffrey, P., Fleming, A., Savage, C. O. S., Meijer, A. H., Jones, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04785-4 · Cited by 14
Adla, S. K., Tonduru, A. K., Kronenberger, T., Kudová, E., Poso, A., & Huttunen, K. M. (2021) · Molecules · doi:10.3390/molecules26185662 · Cited by 12
“Carrier-mediated active uptake is also the primary transport mechanism for most of the CNS-drugs [11], and endogenous solute carriers (SLCs) have a major role in their CNS disposition [12,13].”
BackgroundLee, S., Song, Y., Hong, B. J., MacRenaris, K. W., Mastarone, D. J., O’Halloran, T. V., Meade, T. J., & Nguyen, S. T. (2010) · Angewandte Chemie · doi:10.1002/ange.201004867 · Cited by 13
García‐Sosa, A. T., Oja, M., Hetényi, C., & Maran, U. (2012) · Molecular Informatics · doi:10.1002/minf.201100094 · Cited by 11
Improving bioavailability of nutraceuticals by nanoemulsification
Pund, S., Joshi, A., & Patravale, V. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804305-9.00013-0 · Cited by 14
Distribution of ion pairs into a bilayer lipid membrane and its effect on the ionic permeability
Omatsu, T., Hori, K., Ishida, N., Maeda, K., & Yoshida, Y. (2021) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2021.183724 · Cited by 10
Zaleskaya-Hernik, M., Salam, R., González, M. J., Wilczek, M., Dobrzycki, L. M., Busschaert, N., & Romański, J. (2025) · Chemical Science · doi:10.1039/d5sc00866b · Cited by 10
Abou‐Zied, O. K., Zahid, N. I., Khyasudeen, M. F., Giera, D. S., Thimm, J. C., & Hashim, R. (2015) · Scientific Reports · doi:10.1038/srep08699 · Cited by 10
Redox and apoptotic potential of novel ruthenium complexes in rat blood and heart
Mihajlović, K., Milosavljevic, I. M., Jeremic, J. N., Savić, M., Sretenovic, J. Z., Srejovic, I. M., Zivkovic, V. I., Jovicic, N. U., Paunović, M. G., Bolevich, S., et al. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0349 · Cited by 10
Gabano, E., Zanellato, I., Pinton, G., Moro, L., Ravera, M., & Osella, D. (2022) · Bioinorganic Chemistry and Applications · doi:10.1155/2022/3698391 · Cited by 11
“Te coexistence of the two types of mechanisms for drug uptake is emphasized in several reviews [27, 28].”
Scherz, L. F., Abdel‐Rahman, E. A., Ali, S. S., Schlüter, A. D., & Abdel-Rahman, M. (2017) · MedChemComm · doi:10.1039/c6md00728g · Cited by 10
Generation of a Small Library of Natural Products Designed to Cover Chemical Space Inexpensively
O’Hagan, S., & Kell, D. B. (2019) · doi:10.20900/pf20190005 · Cited by 10
Self-citationPaul, R., & Paul, S. (2021) · Langmuir · doi:10.1021/acs.langmuir.1c01594 · Cited by 10
Ismatullah, H., & Jabeen, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312993 · Cited by 11
Prodrug Strategies in Drug Design
Rautio, J. (2010) · Methods and principles in medicinal chemistry · doi:10.1002/9783527633166.ch1 · Cited by 11
Mukhtar, S., Kiani, Y. S., & Jabeen, I. (2017) · Medicinal Chemistry Research · doi:10.1007/s00044-017-1933-7 · Cited by 9
“Lipophilicity (clogP) and lipophilic efficiency (LipE) calculation Lipophilicity contributes to the overall solubility and permeability of a drug molecule through biomembrane, thus it might affect their ADME-Tox profiles (Dobson and Kell 2008).”
Simpson, D. H., & Scott, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803814-7.00007-1 · Cited by 11
On the Rational Drug Design for Hypertension through NMR Spectroscopy
Chontzopoulou, E., Tzakos, A. G., & Mavromoustakos, T. (2020) · Molecules · doi:10.3390/molecules26010012 · Cited by 10
“, the biophysical forces that govern the interaction of drugs with lipid membranes are similar to those involved in their interaction with proteins, thus it would be a mistake to ignore them [19].”
BackgroundChaulagain, B., & Singh, J. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00811 · Cited by 11
Grixti, J. M., Ayers, D., & Day, P. J. (2021) · Non-Coding RNA · doi:10.3390/ncrna7020027 · Cited by 9
Many are called, few are chosen: the role of science in drug development decisions
Colen, L., Belderbos, R., Kelchtermans, S., & Leten, B. (2023) · The Journal of Technology Transfer · doi:10.1007/s10961-022-09982-6 · Cited by 9
“…problem that could be dealt with later in the development process, there is mounting evidence that scientific knowledge about transport proteins in a drug candidate allows making a much more accurate assessment of its odds of successful development (Dobson & Kell, 2008; Morgan et al., 2012).”
Does transbilayer diffusion have a role in membrane transport of drugs?
Baláž, Š. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.06.003 · Cited by 10
POLYMERIC NANOPARTICLE MEDIATED TARGETED DRUG DELIVERY TO CANCER CELLS
Abdullah, M. (2014) · Apple Academic Press eBooks · doi:10.1201/b17104-2 · Cited by 9
Transporters – The View from Industry
Kohl, C. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900150 · Cited by 8
Mendes, P., Girardi, E., Superti‐Furga, G., & Kell, D. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.16.909507 · Cited by 9
Self-citationSousa, C. F., Kamal, M. A. M., Richter, R., Elamaldeniya, K., Hartmann, R. W., Empting, M., Lehr, C., & Kalinina, O. V. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00767 · Cited by 7
Balk, F., Hollender, J., & Schirmer, K. (2023) · Environment International · doi:10.1016/j.envint.2023.107798 · Cited by 7
Analysis of metabolites in human gut: illuminating the design of gut-targeted drugs
Gil-Pichardo, A., Sánchez-Ruiz, A., & Colmenarejo, G. (2023) · Journal of Cheminformatics · doi:10.1186/s13321-023-00768-y · Cited by 8
“…that systemic drugs have a greater resemblance to systemic metabolites than to random compounds, which can be rationalized in terms of structural similarity that allows them to compete with endogenous metabolites for their interaction with their targets or with their transporters [28–32].”
BackgroundThe Clinical Significance of Drug Transporters in Drug Disposition and Drug Interactions
Thompson, T. N. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7937-7_13 · Cited by 7
Fujiwara, K., Shin, M., HOUGAARD, D. M., & Saita, T. (2010) · Histochemistry and Cell Biology · doi:10.1007/s00418-010-0768-9 · Cited by 7
“may suggest that both the distal tubules and collecting ducts in the kidney might be the sites readily affected by some chemotherapeutic agents (Thiebaut et al. 1987; Sugawara et al. 1988; Gottesman and Pastan 1993; Schaub et al. 1997; Inui et al. 2000; Dobson and Kell 2008).”
BackgroundInfluentialMondal, D., Samantha, L., Datta, A., Chakravarty, G., & Asim, B. (2012) · InTech eBooks · doi:10.5772/33792 · Cited by 8
Role of Pharmacogenetics on Response to Statins: A Genotype-based Approach to Statin Therapy Outcome
Duman, İ. (2014) · Journal of Cardiology and Therapy · Cited by 6
Mirza, N., Vasieva, O., Appleton, R. E., Burn, S. C., Carr, D. F., Crooks, D. A., du Plessis, D., Duncan, R., Farah, J. O., Josan, V., et al. (2016) · Epilepsia · doi:10.1111/epi.13473 · Cited by 7
“28 Similarly, there is no evidence as yet that the transporters of glutamate or of other neurotransmitters can transport therapeutic drugs.”
BackgroundDey, D., Marciano, S., Poryval, A., Groborz, O., Wohlrábová, L., Slanina, T., & Schreiber, G. (2024) · eLife · doi:10.7554/elife.97255 · Cited by 7
Challenges and strategies for nose-to-brain delivery in treating neurological disorders
Li, X., Wang, X., Tong, F., Li, H., Gao, H., & Liu, T. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2583254 · Cited by 9
“Through these pathways, drugs can reach the olfactory bulb and thus diffuse into the brain [32,48,89,90].”
Sharma, K., Koundal, S., Chadha, P., & Saini, H. S. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-30057-y · Cited by 5
“For the active transport, energy is required, and it is provided by the adenosine triphosphate hydrolysis (ATP; primary active mechanism) (Leslie et al. 2005; Dobson and Kell 2008; Sugano et al. 2010; Hagenbuch and Stieger 2013).”
BackgroundZebrafish Oatp1d1 Acts as a Cellular Efflux Transporter of the Anionic Herbicide Bromoxynil
Halbach, K., Aulhorn, S., Lechtenfeld, O. J., Lecluse, M., Leippe, S. C., Reemtsma, T., Seiwert, B., Wagner, S., König, J., & Luckenbach, T. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00371 · Cited by 5
Fujiwara, K., Shin, M., Yoshizaki, Y., Miyazaki, T., & Saita, T. (2012) · Journal of Molecular Histology · doi:10.1007/s10735-012-9406-2 · Cited by 5
“2003; Tsuji 2006; Dobson and Kell 2008; Terada and Inui 2008).”
Munoz-muriedas, J. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735377-00104 · Cited by 5
van Hell, A. J., Klymchenko, A. S., Gueth, D. M., BLITTERSWIJK, W. J. V., Koning, G. A., & Verheij, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.06.006 · Cited by 5
Prodrugs Designed to Target Transporters for Oral Drug Delivery
Warren, M. S., & Rautio, J. (2010) · Methods and principles in medicinal chemistry · doi:10.1002/9783527633166.ch6 · Cited by 5
Passive Diffusion Permeability of the BBB—Examples and SAR
Summerfield, S. G., Jeffrey, P., Sahi, J., & Chen, L. (2015) · Wiley eBooks · doi:10.1002/9781118788523.ch5 · Cited by 6
In vitro model of retinal pigment epithelium for use in drug delivery studies
Mannermaa, E. (2010) · UEF eRepo (University of Eastern Finland) · Cited by 5
Bayoumy, A. B., Derijks, L. J. J., Oldenburg, B., & de Boer, N. K. H. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121497 · Cited by 4
Membrane lipid composition directs the cellular selectivity of antimicrobial metallohelices
Rogers, N. J., Postings, M. L., Dixon, A. M., Moat, J., Shreeve, G., Stuart, L., Waterfield, N. R., & Scott, P. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00973h · Cited by 4
Martinčič, R., Venko, K., Župerl, Š., & Novič, M. (2014) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2014.962082 · Cited by 5
“For most of pharmaceutical drugs in use nowadays these mechanisms were not specifically considered during drug design, but rather occurred serendipitously, by hitchhiking on membrane carriers normally used for the transport of nutrients and intermediary metabolites [4].”
BackgroundEquivalence-by-Design: Targeting In Vivo Drug Delivery Profile
Chen, M., & Lee, V. H. L. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9743-8 · Cited by 4
Introductory Pharmacology for Clinical Practice
Corbett, R. W., & Owens, L. W. (2011) · Journal of Midwifery & Women s Health · doi:10.1111/j.1542-2011.2011.00066.x · Cited by 4
Tuning the efficiency of molecular probes via quinone methide-based in situ labeling
Rabinowitz, Z. M., Anvar, S., Liu, J., Chen, Z., Zhang, Y., Cui, C., Sigler, A. L., & Cui, L. (2025) · RSC Chemical Biology · doi:10.1039/d5cb00138b · Cited by 3
“59,60 We calculated the logarithm of the partition coefficient ( c log P ) values of each probe molecule using ChemDraw Professional version 20.0.04.1 (Table S1) and plotted the cLogP for each probe against the mean fluorescence intensities of CT26.”
InfluentialThe Importance of and Different Approaches to Permeability Determination
Tam, K. Y., Velický, M., & Dryfe, R. A. W. (2012) · IAPC Publishing eBooks · doi:10.5599/obp.7.3 · Cited by 3
“Other transporter proteins that facilitate the uptake of drug molecules have been repor‐ ted, for example the organic anion transporters [3].”
Zahid, N. I., Abou‐Zied, O. K., Saari, N. A. N., & Hashim, R. (2015) · RSC Advances · doi:10.1039/c5ra19794e · Cited by 3
ARSIC, B. B., Barber, J., Čikoš, A., Kadirvel, M., Kostić, E., McBain, A. J., Milićević, J. S., Oates, A., & Regan, A. C. (2022) · Molecules · doi:10.3390/molecules27217280 · Cited by 3
O’Connor, I. A., Veltman, K., Huijbregts, M. A. J., Ragas, A. M. J., Rüssel, F. G. M., & Hendriks, A. J. (2014) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2014.10.007 · Cited by 3
Gabano, E., Ferraris, C., Osella, D., Battaglia, L., & Ravera, M. (2022) · Inorganica Chimica Acta · doi:10.1016/j.ica.2022.120859 · Cited by 3
Absorption of Drugs via Passive Diffusion and Carrier‐Mediated Pathways
Park, M. S., & Chang, J. H. (2011) · Wiley eBooks · doi:10.1002/9781118067598.ch6 · Cited by 3
Biological and Physiological Features of the Gastrointestinal Tract Relevant to Oral Drug Absorption
Ho, P. C. (2011) · Wiley eBooks · doi:10.1002/9781118067598.ch5 · Cited by 4
Challenges and Options for Drug Discovery
Kramer, W. (2016) · Wiley eBooks · doi:10.1002/9783527693405.ch6 · Cited by 4
O’Hagan, S., & Kell, D. B. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/110437 · Cited by 5
“Given the overwhelming evidence [1-20] that pharmaceutical drugs must and do exploit endogenous transporters that normally transport biological metabolites, and that normally any diffusion of such drugs through the phospholipid bilayer portions of undamaged biological membranes is negligible [1; 3; 5-7; 10; 11; 13; 21…”
BackgroundSelf-citationNanoparticle-Based Drug-Delivery Systems Studied by Second Harmonic Generation
Kumal, R. R. (2017) · Louisiana State University · doi:10.31390/gradschool_dissertations.4090 · Cited by 3
Dey, D., Marciano, S., Poryvai, A., Groborz, O., Wohlrábová, L., Slanina, T., & Schreiber, G. (2024) · eLife · doi:10.1101/2023.04.19.537456 · Cited by 6
Adindu, E. A., Edeghor, O. U., Gulack, A. O., Otu, A. B., Imojara, B., Ajaba, M. O., & Ekpong, B. O. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00441-2 · Cited by 2
“MDCK cells are used as models for the intestines and kidneys (Dobson and Kell 2008 ).”
Umbrella Sampling Workflows for Fast-Converging PMF Calculations without Artificial WHAM Constraints
Feddersen, B., & Biggin, P. C. (2026) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.6c00246 · Cited by 2
Impact of Transporters in Oral Absorption: A Case Study ofin Vitroandin VivoOrganic Anion Absorption
Gram, L. K., Rist, G. M., & Steffansen, B. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8001182 · Cited by 2
Jiang, L., Cheng, A., Wang, Y., & Zhang, B. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-458 · Cited by 2
“Approximately 19 of the SLC gene families have been reported to transport xenobiotics including: organic anion polypeptides (SLCO), oligopeptides (SLC15) (Russel et al. 2002; Brandsch et al. 2008; Dobson and Kell 2008; Rubio and Daniel 2008), organic anion/cations (SLC22) (Koepsell et al.”
BackgroundLocalization and Accumulation Studies of Daptomycin in Rats Kidney Using Immunohistochemistry
Yamamoto, Y. L., Yamamoto, Y., Saita, T., & Shin, M. (2020) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.19-00233 · Cited by 2
Gibberellin biosynthesis and signalling in Arabidopsis root growth
Barker, R. J. (2011) · UPT. Syiah Kuala University Library (Syiah Kuala University) · Cited by 4
Höcherl, P. (2010) · University of Regensburg Publication Server (University of Regensburg) · Cited by 3
Isolation and Characterisation of Bioactive Secondary Metabolites from Arctic, Marine Organisms
Hanssen, K. Ø. (2014) · NVA (Nasjonalt vitenarkiv) · Cited by 4
Response to ‘The Need for Speed’, by Matsson et al .
Mendes, P., Oliver, S. G., & Kell, D. B. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.02.004 · Cited by 2
Self-citationMulquiney, P., & Kuchel, P. W. (2003) · CRC Press eBooks · doi:10.1201/9780203503935-8 · Cited by 2
Nies, A. T., Resch, C., & Namisaki, T. (2012) · Wiley eBooks · doi:10.1002/9783527630905.ch7 · Cited by 2
Absorption of Drugs Via Passive Diffusion and Carrier‐Mediated Pathways
Kokate, A., Chang, J. H., & Park, M. S. (2023) · Wiley eBooks · doi:10.1002/9781119660699.ch5 · Cited by 2
Transfer of Small Molecules Across Membrane-Mimetic Interfaces
Velický, M. (2011) · Research Explorer (The University of Manchester) · Cited by 2
Molupe, N., Magwaza, T. M., Mack, J. P., & Nyokong, T. (2025) · Journal of Porphyrins and Phthalocyanines · doi:10.1142/s1088424625501135 · Cited by 1
Protein Modifications for Cellular Protein Delivery
Arafiles, J. V. V., Franke, J., Dubatouka, P., Franz, L., & Hackenberger, C. P. R. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.6c00267 · Cited by 3
Human PK Prediction and Modeling
Grasela, T. H., Lukacova, V., Morris, D., Clark, R. D., Andrews, K. A., & Bolger, M. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12373-x · Cited by 3
Metadata
- Authors
- Dobson, P. D., & Kell, D. B.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Kell, Douglas B.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-03
- Volume
- 7
- Issue
- 3
- Pages
- 205-220
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2157619122
- Cited by
- 475
- References
- 265
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 20 · 2023: 19 · 2022: 18 · 2021: 24 · 2020: 27 · 2019: 20 · 2018: 17 · 2017: 28 · 2016: 36 · 2015: 43 · 2014: 42 · 2013: 29 · 2012: 36
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- Royal Society
- Wolfson Foundation
- Engineering and Physical Sciences Research Council
- Biotechnology and Biological Sciences Research Council (747/1, BB/D007)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- passive diffusion, lipophilicity, membrane transporters, drug discovery, drug development
- MeSH terms
- Animals, Biological Transport, Cell Membrane, Cell Membrane Permeability, Pharmaceutical Preparations, Humans, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.